Literature DB >> 20677354

Angiogenesis: Reducing risk.

Teresa Villanueva.   

Abstract

Year:  2010        PMID: 20677354     DOI: 10.1038/nrc2896

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.

Authors:  Louise E Reynolds; Alan R Watson; Marianne Baker; Tania A Jones; Gabriela D'Amico; Stephen D Robinson; Carine Joffre; Sarah Garrido-Urbani; Juan Carlos Rodriguez-Manzaneque; Estefanía Martino-Echarri; Michel Aurrand-Lions; Denise Sheer; Franca Dagna-Bricarelli; Dean Nizetic; Christopher J McCabe; Andrew S Turnell; Stephanie Kermorgant; Beat A Imhof; Ralf Adams; Elizabeth M C Fisher; Victor L J Tybulewicz; Ian R Hart; Kairbaan M Hodivala-Dilke
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

2.  Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.

Authors:  Kwan-Hyuck Baek; Alexander Zaslavsky; Ryan C Lynch; Carmella Britt; Yoshiaki Okada; Richard J Siarey; M William Lensch; In-Hyun Park; Sam S Yoon; Takashi Minami; Julie R Korenberg; Judah Folkman; George Q Daley; William C Aird; Zygmunt Galdzicki; Sandra Ryeom
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.